World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
14317
World Ranking
2528
National Ranking
1212

Overview

Qing Yi is affiliated with Houston Methodist in the United States and has contributed extensively to research in medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. Their scholarly output spans key areas including immunology, molecular biology, oncology, hematology, and cancer research.

Their research topics cover a range of subjects such as multiple myeloma research and treatments, CAR-T cell therapy research, immune cell function and interaction, ferroptosis and cancer prognosis, cancer, lipids, and metabolism, immunotherapy and immune responses, and cancer immunotherapy and biomarkers.

Qing Yi has published multiple papers in prominent scientific venues. Notable recent papers include:

  • CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability, 2021, Cell Metabolism
  • Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages, 2020, Cancer Research
  • Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma, 2020, Nature Communications
  • A guideline on the molecular ecosystem regulating ferroptosis, 2024, Nature Cell Biology
  • Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9, 2020, Nature Communications

Frequent publication venues where Qing Yi's work appears include:

  • Blood
  • Cancer Research
  • Nature Communications
  • Cell Metabolism
  • Cancer Cell

Qing Yi has collaborated extensively with other researchers. Frequent co-authors include Jianfei Qian, Liuling Xiao, Qiang Wang, Miao Xian, and Wei Xiong.

Best Publications

  • Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

    Xingzhe Ma;Enguang Bi;Yong Lu;Pan Su

  • CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability.

    Xingzhe Ma;Liuling Xiao;Lintao Liu;Lingqun Ye

  • Th9 cells promote antitumor immune responses in vivo

    Yong Lu;Sungyoul Hong;Haiyan Li;Jung Sun Park

  • Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma

    De Ke Jiang;Jielin Sun;Guangwen Cao;Yao Liu

  • Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug–induced apoptosis

    Yuhuan Zheng;Zhen Cai;Zhen Cai;Siqing Wang;Xiang Zhang

  • Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function

    Young Hee Lee;Natalia Martin-Orozco;Natalia Martin-Orozco;Peilin Zheng;Jing Li

  • Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.

    Yuhong Zhou;Yuhong Zhou;Haijun Wang;Wenjing Fang;Jorge E. Romaguer

  • Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells

    Hua Jiang;Wenhao Zhang;Peipei Shang;Hui Zhang

  • Idiotype Immunization Combined With Granulocyte-Macrophage Colony-Stimulating Factor in Myeloma Patients Induced Type I, Major Histocompatibility Complex–Restricted, CD8- and CD4-Specific T-Cell Responses

    Anders Österborg;Qing Yi;Lotta Henriksson;Jan Fagerberg

  • Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

    Hong Qin;Beatrisa Lerman;Ippei Sakamaki;Guowei Wei

  • Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4 + and CD8 + T cells

    Haiyan Li;Sungyoul Hong;Jianfei Qian;Yuhuan Zheng

  • Cancer and the Microenvironment Myeloma-Osteoclast Interactions as a Model

    Shmuel Yaccoby;Michele J. Wezeman;Aminah Henderson;Michele Cottler-Fox

  • Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma

    Hsiang chi Tseng;Wei Xiong;Wei Xiong;Saiaditya Badeti;Yan Yang

  • Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy

    Yue Jin Wen;Rui Min;Guido Tricot;Bart Barlogie

  • Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo

    Liang Zhang;Zhengzi Qian;Zhengzi Qian;Zhen Cai;Zhen Cai;Luhong Sun

  • Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.

    Yi Hu;Jianhong Lin;Jianhong Lin;Hua Fang;Hua Fang;Jing Fang

  • PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma

    Y. Zheng;J. Yang;Jianfei Qian;P. Qiu

  • Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors

    Yong Lu;Yong Lu;Qiang Wang;Gang Xue;Enguang Bi

  • Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity

    Xingzhe Ma;Enguang Bi;Chunjian Huang;Yong Lu

  • Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen.

    Ali Samanci;Qing Yi;Jan Fagerberg;Karin Strigård

  • Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells

    Yue Jin Wen;Bart Barlogie;Qing Yi

  • Human C-Reactive Protein Binds Activating Fcγ Receptors and Protects Myeloma Tumor Cells from Apoptosis

    Jing Yang;Michele Wezeman;Xiang Zhang;Pei Lin

Frequent Co-Authors

Larry W. Kwak
Larry W. Kwak City Of Hope National Medical Center
Anders Österborg
Anders Österborg Karolinska Institute
Håkan Mellstedt
Håkan Mellstedt Karolinska Institute
Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Robert Z. Orlowski
Robert Z. Orlowski The University of Texas MD Anderson Cancer Center
Long Yu
Long Yu Fudan University
Magnus Björkholm
Magnus Björkholm Karolinska University Hospital
Joshua Epstein
Joshua Epstein University of Arkansas for Medical Sciences
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center
Mahmood Jeddi-Tehrani
Mahmood Jeddi-Tehrani Avicenna Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, pursuing related fields such as nursing can open diverse career pathways. One popular option is becoming a nurse practitioner, where aspiring professionals can explore some of the easiest nurse practitioner degree programs online. These programs are designed to accommodate students with varying academic backgrounds, making it more accessible to enter healthcare-focused roles.

Specializations like psychiatric mental health nursing are in high demand. The best online pmhnp programs stand out by offering strong clinical placement rates, ensuring graduates gain invaluable hands-on experience. Additionally, those mindful of costs can consider the cheapest pmhnp certificate programs, which provide quality education at a lower price point.

Career prospects for advanced degrees are promising, with salaries varying by location. For example, a doctor of nursing practice salary can be significantly higher in certain states, reflecting regional demand and cost of living. Exploring these online degree options helps immunology enthusiasts broaden their expertise and access impactful healthcare careers.

Best Scientists Citing Qing Yi

Trending Scientists

Recently Published Articles